You are here: Industry Insights > Biology

News List

Decoding the Role of Synthetic Biology in Pharmaceuticals Neeta Ratanghayra
October 16, 2024
Recognized for its transformative potential, synthetic biology has emerged as a technology poised to revolutionize various industries, including pharmaceuticals.
Sai Life Sciences to Expand Biology Capabilities contractpharma
October 29, 2020
Sai Life Sciences, one of India's fastest growing contract research, development and manufacturing organizations (CRDMO), unveiled plans to significantly expand its biology capabilities at its integrated R&D campus in Hyderabad ...
Algorithm Based on Response, Biology Guides Neuroblastoma Tx drugs
September 06, 2019
Use of a response- and biology-based treatment algorithm for intermediate-risk neuroblastoma is associated with excellent survival and reduces treatment for some patients
Viruses may play a role in Alzheimer’s disease biospectrumasia
June 25, 2018
The research group and Arizona State University, Phoenix, originally set out to find whether drugs used to treat other diseases can be repurposed for treating Alzheimer’s.
Synthetic Genomics Launches cGMP Synthetic Biology Suite contractpharma
June 05, 2017
Synthetic Genomics, Inc. and Advaxis, Inc. have completed development and deployment of the first cGMP synthetic biology facility for the production of synthetic DNA constructs.
Intrexon to Acquire GenVec to Expand Industry-Leading Gene Delivery Platform firstwordpharma
January 25, 2017
Intrexon Corporation (NYSE: XON) announced that it has entered into a definitive agreement to acquire GenVec, Inc. (NASDAQ: GNVC), a clinical-stage company and pioneer in the development of AdenoVerse™ gene delivery technology.